The New Delhi Bench of Customs, Excise, and Service Tax Appellate Tribunal (CESTAT) has stated that HIV-VL test kits qualify ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

As mpox cases rise again in parts of Central Africa, the Democratic Republic of the Congo is pioneering an integrated public health response for HIV ...

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...

We went back 50 years to detail the history of Kansas City’s LGBTQ+ community and their fight for equal rights and the ...

Koforidua, July 01, GNA – A Report by Ghana HIV and AIDS Network (GHANET), as part of its Community HIV self-testing project, ...

Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...

Mathematical models indicate that the worst-case scenario of the Trump administration’s HIV-related cuts could result in 3 ...

The 'Silence=Death' poster from the early years of the AIDS crisis holds true today with the possibility of federal cuts to ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

Learn what a negative HIV test means, why the window period matters, and when you should consider retesting. Essential health ...